ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $69,000 | -10.4% | 6,214 | -32.9% | 0.06% | +1.6% |
| Q1 2017 | $77,000 | -76.0% | 9,256 | -80.0% | 0.06% | -51.5% |
| Q4 2016 | $321,000 | +13.8% | 46,220 | -16.6% | 0.13% | -29.8% |
| Q3 2016 | $282,000 | +27.6% | 55,444 | +50.1% | 0.19% | +14.6% |
| Q2 2016 | $221,000 | -19.0% | 36,942 | -38.5% | 0.16% | -13.2% |
| Q1 2016 | $273,000 | – | 60,106 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
| CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
| KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
| First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
| Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
| MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
| Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
| EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
| ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |